Abstract
Background: Orthosiphon stamineus is a medicinal herb rich in caffeic acid derivatives. Rosmarinic acid is one of the caffeic acid-based phytochemicals which is also well-known for its antioxidant and anti-inflammatory properties.
Objective: This study was focused on the preparation of rosmarinic acid-rich fraction to enhance the antioxidant capacity of O. stamineus. Method: The rosmarinic acid-rich fraction was prepared by using an integrated technique of reflux extraction and column chromatography. The concentration of ethanol was varied from 0-100 %v/v to optimize the yield of rosmarinic acid in the fraction. Results: This technique increased the rosmarinic acid content from 0.14 %w/w in the dried whole plant to 1.9 %w/w in the crude extract till 4.1 %w/w in the 80 %v/v ethanol fraction. The consecutive elution of packed column also produced eupatorin-rich fraction from 0.0008 %w/w in the dried whole plant to 0.17 %w/w in the crude extract and 0.5 %w/w in the 40 %v/v ethanol fraction. The increment of rosmarinic acid content enhanced the radical scavenging activity in the fractions. The IC50 was significantly decreased from 2424 to 37.7 ppm for the crude extract and its 80 %v/v ethanol fraction, respectively. Therefore, the increase of rosmarinic acid content also increased the antioxidant capacity of the plant extract. Conclusion: This rosmarinic acid-rich fraction could be further developed into various useful herbal products for the benefits of mankind.Keywords: Herbal plant, Orthosiphon stamineus, rosmarinic acid, eupatorin, reflux extraction, column chromatography.
The Natural Products Journal
Title:Reflux Extraction and Column Chromatography for Rosmarinic Acid- Rich Fraction from Orthosiphon stamineus
Volume: 7 Issue: 1
Author(s): Lee Suan Chua and Cher Haan Lau
Affiliation:
Keywords: Herbal plant, Orthosiphon stamineus, rosmarinic acid, eupatorin, reflux extraction, column chromatography.
Abstract: Background: Orthosiphon stamineus is a medicinal herb rich in caffeic acid derivatives. Rosmarinic acid is one of the caffeic acid-based phytochemicals which is also well-known for its antioxidant and anti-inflammatory properties.
Objective: This study was focused on the preparation of rosmarinic acid-rich fraction to enhance the antioxidant capacity of O. stamineus. Method: The rosmarinic acid-rich fraction was prepared by using an integrated technique of reflux extraction and column chromatography. The concentration of ethanol was varied from 0-100 %v/v to optimize the yield of rosmarinic acid in the fraction. Results: This technique increased the rosmarinic acid content from 0.14 %w/w in the dried whole plant to 1.9 %w/w in the crude extract till 4.1 %w/w in the 80 %v/v ethanol fraction. The consecutive elution of packed column also produced eupatorin-rich fraction from 0.0008 %w/w in the dried whole plant to 0.17 %w/w in the crude extract and 0.5 %w/w in the 40 %v/v ethanol fraction. The increment of rosmarinic acid content enhanced the radical scavenging activity in the fractions. The IC50 was significantly decreased from 2424 to 37.7 ppm for the crude extract and its 80 %v/v ethanol fraction, respectively. Therefore, the increase of rosmarinic acid content also increased the antioxidant capacity of the plant extract. Conclusion: This rosmarinic acid-rich fraction could be further developed into various useful herbal products for the benefits of mankind.Export Options
About this article
Cite this article as:
Chua Suan Lee and Lau Haan Cher, Reflux Extraction and Column Chromatography for Rosmarinic Acid- Rich Fraction from Orthosiphon stamineus, The Natural Products Journal 2017; 7 (1) . https://dx.doi.org/10.2174/2210315506666161007114834
DOI https://dx.doi.org/10.2174/2210315506666161007114834 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |
Call for Papers in Thematic Issues
Ayurvedic medicinal therapeutic approaches for inflammatory and neurodegenerative disorders
Usually, in our elderly population, neurodegenerative disorders occur due to neuron death. Alzheimer?s disease (AD) is an irreversible and progressive neurodegenerative disease. Dementia is the leading cause of AD, which affects about 30 million people worldwide. According to the World Alzheimer report 2018, a new case of dementia develops every ...read more
Recent Advances in Biotransformation of Bioactive Terpenoids using Aspergillus niger
Biotransformation is the reaction catalyzed by biological catalysts of either isolated enzymes or whole cell cultures of microorganisms. This process has been extensively applied in the conversion of bioactive terpenoids with high regio- and stereospecifity. This process has been also applied in the lead discovery and development. Aspergillus niger has ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
SELDI Protein Chip Technology for the Detection of Serum Biomarkers for Liver Disease
Protein & Peptide Letters Synthesis, In Vitro Activities of (2-Cyclopropoxyphenyl)piperidine Derivatives for α1a and α1d Adrenergic Receptor Inhibitors
Medicinal Chemistry Inventions Designed to Enhance Drug Delivery Across Epithelial and Endothelial Cells Through the Paracellular Pathway
Recent Patents on Drug Delivery & Formulation Arsenic Immunotoxicity and Immunomodulation by Phytochemicals: Potential Relations to Develop Chemopreventive Approaches
Recent Patents on Inflammation & Allergy Drug Discovery Tyrosine Kinase Inhibitor-Induced Hypertension: Role of Hypertension as a Biomarker in Cancer Treatment
Current Vascular Pharmacology Herbal Medicines for Diabetes Management and its Secondary Complications
Current Diabetes Reviews Physicochemical Properties that Determine Cellular Transport of Nanocarriers In Vitro and In Vivo
Current Organic Chemistry Patent Selections
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Mammaglobin-Based Strategies for Treatment of Breast Cancer
Current Cancer Drug Targets Recent Findings on the Application of Toll-like Receptors Agonists in Cancer Therapy
Current Medicinal Chemistry Molecular and Genetic Profiling of Prostate Cancer: Implications for Future Therapy
Current Cancer Therapy Reviews Immunomodulatory Roles of VIP and PACAP in Models of Multiple Sclerosis
Current Pharmaceutical Design Organ Preservation by the Association of Chemotherapy and Radiotherapy in Invasive Bladder Cancer
Current Drug Therapy Functional Nanoplatforms for Enhancement of Chemotherapeutic Index
Anti-Cancer Agents in Medicinal Chemistry Peptides Targeting Gap Junctional Structures
Current Pharmaceutical Design Strategies for the Assessment of Metabolic Profiles of Steroid Hormones in View of Diagnostics and Drug Monitoring: Analytical Problems and Challenges
Current Drug Metabolism Differentiation-Inducing Therapy for Solid Tumors
Current Pharmaceutical Design The Anti-Tumor Activity of Afatinib in Pancreatic Ductal Adenocarcinoma Cells
Anti-Cancer Agents in Medicinal Chemistry Impact of Drug Metabolism/Pharmacokinetics and their Relevance Upon Taxus-based Drug Development
Current Drug Metabolism Role of NF-κB in the Regulation of Cytochrome P450 Enzymes
Current Drug Metabolism